Cargando…
Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine
Despite current advancements in chemotherapy, immunotherapy and targeted treatments, the potential for major adverse cardiovascular events, regardless of previous cardiac history, persists. Scoring systems, such as the Heart Failure Association-International Cardio-Oncology Society (HFA-ICOS) risk a...
Autores principales: | Samuel, Younan, Babu, Aswin, Karagkouni, Foteini, Ismail, Ayden, Choi, Sunyoung, Boussios, Stergios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605822/ https://www.ncbi.nlm.nih.gov/pubmed/37886969 http://dx.doi.org/10.3390/cimb45100526 |
Ejemplares similares
-
HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
por: Choi, Sunyoung, et al.
Publicado: (2023) -
State-of-the-Art Molecular Oncology in UK
por: Sandoughdaran, Saleh, et al.
Publicado: (2023) -
Biobanking in the era of precision oncology
por: Saini, Kamal S., et al.
Publicado: (2015) -
Biomarkers in the Era of Precision Oncology
por: Baxevanis, Constantin N.
Publicado: (2023) -
Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
por: Boussios, Stergios, et al.
Publicado: (2021)